JAB-8263

· Jacobio Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JAB-8263, covering 2026-01-09 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors [Phase 1]